Institute of Microbiology and Epizootics, Centre for Infection Medicine, Department of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Beijing Key Laboratory of Detection Technology for Animal-Derived Food Safety, College of Veterinary Medicine, China Agricultural University, Beijing, People's Republic of China.
Clin Microbiol Rev. 2021 Jun 16;34(3):e0018820. doi: 10.1128/CMR.00188-20. Epub 2021 Jun 2.
Seven mobile oxazolidinone resistance genes, including , (B), (C), (D), (E), , and , have been identified to date. The genes code for 23S rRNA methylases, which confer a multiresistance phenotype that includes resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A compounds. The and genes code for ABC-F proteins that protect the bacterial ribosomes from the inhibitory effects of oxazolidinones. The gene confers resistance to oxazolidinones and phenicols, while the gene confers elevated MICs or resistance to oxazolidinones, phenicols, and tetracycline. These oxazolidinone resistance genes are most frequently found on plasmids, but they are also located on transposons, integrative and conjugative elements (ICEs), genomic islands, and prophages. In these mobile genetic elements (MGEs), insertion sequences (IS) most often flanked the , , and genes and were able to generate translocatable units (TUs) that comprise the oxazolidinone resistance genes and occasionally also other genes. MGEs and TUs play an important role in the dissemination of oxazolidinone resistance genes across strain, species, and genus boundaries. Most frequently, these MGEs also harbor genes that mediate resistance not only to antimicrobial agents of other classes, but also to metals and biocides. Direct selection pressure by the use of antimicrobial agents to which the oxazolidinone resistance genes confer resistance, but also indirect selection pressure by the use of antimicrobial agents, metals, or biocides (the respective resistance genes against which are colocated on -, -, or -carrying MGEs) may play a role in the coselection and persistence of oxazolidinone resistance genes.
目前已经鉴定出了 7 种移动的恶唑烷酮类耐药基因,包括、、、、、和。这些基因编码 23S rRNA 甲基化酶,使细菌具有多药耐药表型,包括对苯氧甲基青霉素类、林可酰胺类、恶唑烷酮类、截短侧耳素类和糖肽类化合物的耐药性。和基因编码 ABC-F 蛋白,可保护细菌核糖体免受恶唑烷酮类药物的抑制作用。基因赋予对恶唑烷酮类和苯氧甲基青霉素类的耐药性,而基因赋予对恶唑烷酮类、苯氧甲基青霉素类和四环素的 MIC 升高或耐药性。这些恶唑烷酮类耐药基因最常存在于质粒上,但也位于转座子、整合和共轭元件 (ICEs)、基因组岛和噬菌体内。在这些移动遗传元件 (MGEs) 中,插入序列 (IS) 最常侧翼携带、和基因,并能够产生包含恶唑烷酮类耐药基因的可转移单位 (TU),偶尔还包含其他基因。MGEs 和 TUs 在恶唑烷酮类耐药基因在菌株、物种和属之间的传播中起着重要作用。这些 MGEs 最常携带不仅介导对其他类别抗菌药物,而且还介导对金属和消毒剂耐药性的基因。对恶唑烷酮类耐药基因赋予耐药性的抗菌药物的直接选择压力,以及对金属或消毒剂的间接选择压力(各自的耐药基因位于携带 -、- 或 - 的 MGEs 上)可能在恶唑烷酮类耐药基因的共选择和持续存在中发挥作用。